Covered recipient · General Payments record
ERIC J BIONDO SAVIN
Allopathic & Osteopathic Physicians Radiology Neuroradiology
General Payments · PY2020–2024
$1,053.18
- Reported across 55 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $356.22 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $91.93 | 4 |
| Lilly USA, LLC | $64.79 | 4 |
| Amgen Inc. | $55.50 | 3 |
| EISAI INC. | $50.28 | 2 |
| Lundbeck LLC | $20.66 | 1 |
| Xeris Pharmaceuticals, Inc. | $19.55 | 1 |
| Biogen, Inc. | $18.80 | 1 |
| ACADIA Pharmaceuticals Inc | $17.70 | 1 |
| SK Life Science, Inc. | $17.01 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ACADIA Pharmaceuticals Inc | $17.70 | 07/25/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1147963929 | CMS |
| Amgen Inc. | $17.44 | 01/10/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1111530654 | CMS |
| Amgen Inc. | $21.25 | 02/05/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1111530656 | CMS |
| Amgen Inc. | $16.81 | 04/26/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1111530658 | CMS |
| Biogen, Inc. | $18.80 | 04/02/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1104866076 | CMS |
| Eisai Inc. | $24.16 | 05/15/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1110744163 | CMS |
| Eisai Inc. | $26.12 | 07/11/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1110744161 | CMS |
| Lilly USA, LLC | $18.49 | 02/29/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1136163252 | CMS |
| Lilly USA, LLC | $15.11 | 03/12/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1134967309 | CMS |
| Lilly USA, LLC | $16.04 | 05/02/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1134973311 | CMS |
| Lilly USA, LLC | $15.15 | 07/29/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1134967311 | CMS |
| Lundbeck LLC | $20.66 | 02/23/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1145897890 | CMS |
| SK Life Science, Inc. | $17.01 | 08/28/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1154124703 | CMS |
| Teva Pharmaceuticals USA, Inc. | $13.09 | 04/03/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1151688464 | CMS |
| Teva Pharmaceuticals USA, Inc. | $20.13 | 06/04/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1151688508 | CMS |
| Teva Pharmaceuticals USA, Inc. | $13.26 | 06/09/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1151688511 | CMS |
| Teva Pharmaceuticals USA, Inc. | $45.45 | 07/25/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1151688544 | CMS |
| Xeris Pharmaceuticals, Inc. | $19.55 | 06/26/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1144594044 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.